In mechanisms underlying immune comorbidities, KIF4A serves as a shared hub gene in both psoriasis and Crohn’s disease, enriched in cell cycle and immune pathways; treatments like etoposide can ameliorate comorbid progression by downregulating its expression, indicating KIF4A’s role in these interconnected mechanisms [125]. The gene discussed is KIF4A; the disease is Crohn disease.